✦ LIBER ✦

Development of biomarkers: What are the scientific hurdles?

✍ Scribed by L. Håkansson

Book ID: 119233602
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 122 KB
Volume: 5
Category: Article
ISSN: 1359-6349
DOI: 10.1016/j.ejcsup.2007.09.012

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Achieving clinical transplant tolerance:

Achieving clinical transplant tolerance: what are the hurdles?

✍ A.D. Salamam; M.H. Sayegh 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 47 KB

What Are the Biomarkers for Glaucoma?

✍ Olga Golubnitschaja; Josef Flammer 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 401 KB

Exercise18FDG Imaging for the Detection

Exercise18FDG Imaging for the Detection of CAD: What Are the Clinical Hurdles?

✍ Diwakar Jain; Zuo-Xiang He; Afshin Ghanbarinia 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 461 KB

Offline: What are scientific publishers

Offline: What are scientific publishers for?

✍ Horton, Richard 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 510 KB

The work-family balance: What hurdles ar

The work-family balance: What hurdles are parents leaving welfare likely to confront?

✍ S. Jody Heymann; Alison Earle 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB

States may exempt up to 20 percent of the caseload from the 5-year lifetime limit for hardship reasons but whether states will exempt 20 percent and, if so, whom they will exempt, is likely to vary from state to state.

The use of induced pluripotent stem cell

The use of induced pluripotent stem cells for disease modeling: what are the promises and hurdles?

✍ Li, Ronald A. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 145 KB